Compound details
Adenosine
| Compound ID | CDAMM00323 |
|---|---|
| Common name | Adenosine | IUPAC name | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
| Molecular formula | C10H13N5O4 |
| Retention time | 10.942 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 268.105 | Theoretical mz | 268.104 |
| Error | 2.87 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 8.01 |
| Inchi key | OIRDTQYFTABQOQ-KQYNXXCUSA-N |
|---|---|
| Smiles | OCC1OC(N2C=NC=3C(=NC=NC32)N)C(O)C1O |
| Superclass | Nucleosides, nucleotides, and analogues |
| Class | Purine nucleosides |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| Q86X55 | CARM1 | Histone-arginine methyltransferase CARM1 | T12837 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction and SEA |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction and SEA |
| P07327 | ADH1A | Alcohol dehydrogenase alpha chain | T65570 | SEA |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| Q07820 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | T14912 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction and SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P10253 | GAA | Lysosomal alpha-glucosidase (by homology) | T31514 | SwissTargetPrediction |
| P27487 | DPP4 | Dipeptidyl peptidase IV | T31391 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SwissTargetPrediction and SEA |
| P11086 | PNMT | Phenylethanolamine N-methyltransferase | T56496 | SwissTargetPrediction |
| P29275 | ADORA2B | Adenosine A2b receptor | T86679 | SwissTargetPrediction and SEA |
| P00491 | PNP | Purine nucleoside phosphorylase | T78198 | SwissTargetPrediction and SEA |
| P04183 | TK1 | Thymidine kinase, cytosolic | T30081 | SEA |
| P14902 | IDO1 | Indoleamine 2,3-dioxygenase | T89697 | SwissTargetPrediction |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SwissTargetPrediction |
| P09467 | FBP1 | Fructose-1,6-bisphosphatase | T83391 | SwissTargetPrediction and SEA |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1 | T49639 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P26358 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 (by homology) | T88304 | SEA |
| P32320 | CDA | Cytidine deaminase (by homology) | T79027 | SwissTargetPrediction and SEA |
| P00813 | ADA | Adenosine deaminase | T03661 | SwissTargetPrediction and SEA |
| P04062 | GBA | Beta-glucocerebrosidase | T84173 | SwissTargetPrediction |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| P55263 | ADK | Adenosine kinase | T91661 | SwissTargetPrediction and SEA |
| O60502 | OGA | Bifunctional protein NCOAT | T19567 | SwissTargetPrediction |
| P11142 | HSPA8 | Heat shock cognate 71 kDa protein | T12817 | SwissTargetPrediction |
| P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase liver | T39321 | SwissTargetPrediction and SEA |
| Q99808 | SLC29A1 | Equilibrative nucleoside transporter 1 | T13491 | SwissTargetPrediction and SEA |
| P11021 | HSPA5 | 78 kDa glucose-regulated protein | T77594 | SwissTargetPrediction |
| O43868 | SLC28A2 | Sodium/nucleoside cotransporter 2 | T94627 | SwissTargetPrediction and SEA |
| P23526 | AHCY | Adenosylhomocysteinase | T68698 | SwissTargetPrediction and SEA |
| P16455 | MGMT | 6-O-methylguanine-DNA methyltransferase | T24587 | SEA |
| P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | T40111 | SEA |
| P12268 | IMPDH2 | Inosine-5'-monophosphate dehydrogenase 2 | T89360 | SEA |
| Q9H244 | P2RY12 | Purinergic receptor P2Y12 (by homology) | T46937 | SEA |
| P19971 | TYMP | Thymidine phosphorylase | T59929 | SEA |
| Q8TEK3 | DOT1L | Histone-lysine N-methyltransferase, H3 lysine-79 specific | T87686 | SwissTargetPrediction and SEA |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SEA |
| P55786 | NPEPPS | Puromycin-sensitive aminopeptidase | T15610 | SEA |
| P47900 | P2RY1 | Purinergic receptor P2Y1 | T67818 | SwissTargetPrediction and SEA |
| P41231 | P2RY2 | Purinergic receptor P2Y2 | T93515 | SEA |
| P63000 | RAC1 | Ras-related C3 botulinum toxin substrate 1 | T88752 | SEA |
| Q15910 | EZH2 | EZH2/SUZ12/EED/RBBP7/RBBP4 | T25265 | SwissTargetPrediction and SEA |
| Q99873 | PRMT1 | Protein-arginine N-methyltransferase 1 | T16808 | SwissTargetPrediction and SEA |
| Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | T53251 | SwissTargetPrediction and SEA |
| P16885 | PLCG2 | Phospholipase C-gamma-2 | T93922 | SEA |
| Q9Y478 | PRKAB1 | AMP-activated protein kinase, beta-1 subunit | T38875 | SEA |
| Q13126 | MTAP | S-methyl-5-thioadenosine phosphorylase | T40787 | SwissTargetPrediction |
| P06865 | HEXA | Beta-hexosaminidase subunit alpha | T63196 | SEA |
| P07686 | HEXB | Beta-N-acetyl-D-hexosaminidase-A/B | T63197 | SEA |
| P23919 | DTYMK | Thymidylate kinase | T94400 | SEA |
| Q9NRG4 | SMYD2 | N-lysine methyltransferase SMYD2 | T15797 | SwissTargetPrediction and SEA |
| O94759 | TRPM2 | Transient receptor potential cation channel subfamily M member 2 | T78205 | SEA |
| P41252 | IARS | Isoleucyl-tRNA synthetase | T46515 | SwissTargetPrediction |
| Q9H9B1 | EHMT1 | Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 | T39996 | SwissTargetPrediction and SEA |
| Q9UBC3 | DNMT3B | DNA (cytosine-5)-methyltransferase 3B | T65501 | SwissTargetPrediction and SEA |
| Q15391 | P2RY14 | Purinergic receptor P2Y14 | T16555 | SEA |
| P49789 | FHIT | Bis(5'-adenosyl)-triphosphatase | T59720 | SwissTargetPrediction |
| Q05823 | RNASEL | RNase L | T25200 | SEA |
| P51575 | P2RX1 | P2X purinoceptor 1 | T69091 | SwissTargetPrediction and SEA |
| P17707 | AMD1 | S-adenosylmethionine decarboxylase 1 | T55922 | SwissTargetPrediction and SEA |
| Q8WTS6 | SETD7 | Histone-lysine N-methyltransferase SETD7 | T73184 | SwissTargetPrediction and SEA |
| Q9NVM4 | PRMT7 | Protein arginine N-methyltransferase 7 | T79501 | SwissTargetPrediction and SEA |
| Q9BYW2 | SETD2 | Histone-lysine N-methyltransferase SETD2 | T73551 | SwissTargetPrediction |
| O43463 | SUV39H1 | Histone-lysine N-methyltransferase SUV39H1 | T39519 | SwissTargetPrediction and SEA |
| Q92800 | EZH1 | Histone-lysine N-methyltransferase EZH1 | T17986 | SwissTargetPrediction and SEA |
| Q99571 | P2RX4 | P2X purinoceptor 4 | T60330 | SEA |
| Q13304 | GPR17 | Uracil nucleotide/cysteinyl leukotriene receptor | T33902 | SEA |
| Q86Y97 | KMT5C | Histone-lysine N-methyltransferase KMT5C | T68490 | SEA |
| O95622 | ADCY5 | Adenylate cyclase type 5 | T19531 | SEA |
| Q9NZ70 | TAK1 | TGF-beta-activated kinase 1 | T04361 | SEA |
| Q9Y4W7 | PARG | Poly(ADP-ribose) glycohydrolase | T66935 | SwissTargetPrediction and SEA |
| Q07108 | CD69 | Early activation antigen CD69 | T48780 | SEA |
| O60755 | GALR3 | Galanin receptor | T98494 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T65570 | DI0139 | Exposure to noxious substances harmful effect | [ICD-11: NE61] | P07327 | ADH1A |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T14912 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q07820 | MCL1 |
| T14912 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q07820 | MCL1 |
| T14912 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q07820 | MCL1 |
| T14912 | DI0252 | Melanoma | [ICD-11: 2C30] | Q07820 | MCL1 |
| T14912 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q07820 | MCL1 |
| T14912 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q07820 | MCL1 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T31514 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | P10253 | GAA |
| T31391 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P27487 | DPP4 |
| T31391 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P27487 | DPP4 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T86679 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P29275 | ADORA2B |
| T86679 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P29275 | ADORA2B |
| T78198 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P00491 | PNP |
| T78198 | DI0167 | Gout | [ICD-11: FA25] | P00491 | PNP |
| T78198 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P00491 | PNP |
| T78198 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P00491 | PNP |
| T78198 | DI0351 | Psoriasis | [ICD-11: EA90] | P00491 | PNP |
| T30081 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P04183 | TK1 |
| T30081 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P04183 | TK1 |
| T89697 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14902 | IDO1 |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T83391 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P09467 | FBP1 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T49639 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P0DMV8 | HSPA1A |
| T49639 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P0DMV8 | HSPA1A |
| T49639 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P0DMV8 | HSPA1A |
| T49639 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P0DMV8 | HSPA1A |
| T49639 | DI0260 | Metastatic malignant neoplasm | [ICD-11: 2D50-2E09] | P0DMV8 | HSPA1A |
| T49639 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P0DMV8 | HSPA1A |
| T49639 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMV8 | HSPA1A |
| T49639 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P0DMV8 | HSPA1A |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T88304 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P26358 | DNMT1 |
| T88304 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P26358 | DNMT1 |
| T88304 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P26358 | DNMT1 |
| T79027 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P32320 | CDA |
| T03661 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P00813 | ADA |
| T03661 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P00813 | ADA |
| T03661 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P00813 | ADA |
| T84173 | DI0257 | Metabolic disorder | [ICD-11: 5C50-5D2Z] | P04062 | GBA |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T91661 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P55263 | ADK |
| T19567 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O60502 | OGA |
| T19567 | DI0331 | Parkinsonism | [ICD-11: 8A00] | O60502 | OGA |
| T39321 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P04406 | GAPDH |
| T39321 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04406 | GAPDH |
| T13491 | DI0030 | Angina pectoris | [ICD-11: BA40] | Q99808 | SLC29A1 |
| T77594 | DI0252 | Melanoma | [ICD-11: 2C30] | P11021 | HSPA5 |
| T77594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11021 | HSPA5 |
| T24587 | DI0369 | Sarcoma | [ICD-11: 2A60-2C35] | P16455 | MGMT |
| T40111 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P20839 | IMPDH1 |
| T40111 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P20839 | IMPDH1 |
| T40111 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P20839 | IMPDH1 |
| T40111 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P20839 | IMPDH1 |
| T40111 | DI0413 | Transplant rejection | [ICD-11: NE84] | P20839 | IMPDH1 |
| T89360 | DI0413 | Transplant rejection | [ICD-11: NE84] | P12268 | IMPDH2 |
| T46937 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q9H244 | P2RY12 |
| T46937 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | Q9H244 | P2RY12 |
| T59929 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P19971 | TYMP |
| T87686 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q8TEK3 | DOT1L |
| T87686 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q8TEK3 | DOT1L |
| T87686 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q8TEK3 | DOT1L |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T15610 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P55786 | NPEPPS |
| T15610 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P55786 | NPEPPS |
| T93515 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P41231 | P2RY2 |
| T88752 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P63000 | RAC1 |
| T25265 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | Q15910 | EZH2 |
| T16808 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99873 | PRMT1 |
| T53251 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q96KQ7 | EHMT2 |
| T53251 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q96KQ7 | EHMT2 |
| T53251 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96KQ7 | EHMT2 |
| T38875 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q9Y478 | PRKAB1 |
| T40787 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | Q13126 | MTAP |
| T63196 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | P06865 | HEXA |
| T63197 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | P07686 | HEXB |
| T15797 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9NRG4 | SMYD2 |
| T15797 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NRG4 | SMYD2 |
| T39996 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9H9B1 | EHMT1 |
| T39996 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H9B1 | EHMT1 |
| T65501 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBC3 | DNMT3B |
| T59720 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P49789 | FHIT |
| T55922 | DI0004 | Acidosis | [ICD-11: 5C73] | P17707 | AMD1 |
| T73184 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q8WTS6 | SETD7 |
| T17986 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q92800 | EZH1 |
| T17986 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q92800 | EZH1 |
| T17986 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q92800 | EZH1 |
| T17986 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q92800 | EZH1 |
| T17986 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | Q92800 | EZH1 |
| T17986 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | Q92800 | EZH1 |
| T17986 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92800 | EZH1 |
| T17986 | DI0423 | Ureteral cancer | [ICD-11: 2C92] | Q92800 | EZH1 |
| T04361 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q9NZ70 | TAK1 |
| T98494 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | O60755 | GALR3 |